Jennifer Krohn

Bio:

Jennifer Krohn, MS, currently serves as Associate Director, RBQM at Gilead Sciences. In her role, Jenn advises study teams on implementing risk based strategies and leads initiatives working to develop enhanced technology and processes for centralized monitoring, risk assessments, and site monitoring approaches. This role expands upon her prior 16 years' experience in the CRO sector, where she spent a decade helping build centralized monitoring, leading data analyst teams, and serving as QTL BPO. Prior to the RBQM space, Jenn worked in a variety of clinical trial roles across a wide range of therapeutic areas, from the site level as study coordinator, to the CRO side in Clinical (CRA), Data Management, and Feasibility. 

Jenn co-leads the PHUSE RBQM Working Group and previously co-lead the PHUSE Central Monitoring project. Jenn holds a master's degree in Biology with a focus in biochemistry and physiology from the University of North Carolina Wilmington.